4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-062075
Chief Business Officer sold 2,774 shares at an average $28.27 ($78,420)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McNeill Jonathan Chief Business Officer | 2024-05-16 | Sale 10b5-1 | −2,279 | $28.20 | $64,268 | 137,129 | D |
| McNeill Jonathan Chief Business Officer | 2024-05-16 | Sale 10b5-1 | −495 | $28.59 | $14,152 | 136,634 | D |
| Open-market sales · 2,774 sh · avg $28.27 · $78,420 | |||||||
Loading xslF345X05/ownership.xml…